A new mechanism for lupus
Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune
Billing codes aid lupus diagnosis
April Barnado, MD, MSCI, and colleagues screened de-identified electronic health records (EHRs) that are linked to genotyped blood samples stored in Vanderbilt University Medical Center’s BioVU biobank.
Division faculty helping patients with undiagnosed diseases
VUMC, an original member institution of the NIH program, announced it is launching its own program, the Vanderbilt Undiagnosed Diseases Program (VUDP), which will operate alongside the NIH program. The VUDP goal is to expand services to many more patients who are living with the often-dire consequences of an undiagnosed disease.
Dr. Crofford receives President’s Award from Tennessee Rheumatology Society
Dr. Leslie Crofford was presented with the President’s Award at the 2023 meeting of the Tennessee Rheumatology Society.
Azathioprine Tests Pharmacogenetics in Rheumatology
A team of researchers, led by Cecilia Chung, M.D., an associate professor in the Division of Rheumatology at Vanderbilt University Medical Center, published a review in Clinical Rheumatology using azathioprine as a high-stakes example of how pharmacogenetics can help rheumatologists prescribe wisely and the potential of developing risk scores.
Nutraceutical in Buckwheat Cleans Up RA Inflammation
2-HOBA hunts down the isolevuglandins responsible for proinflammatory cytokines in rheumatoid arthritis.
Three-decade Review Clarifies Pregnancy Risk in Lupus
Researchers find higher risks of adverse events, underutilized options for mitigation.
VUMC lauded for scleroderma treatment, research
Vanderbilt University Medical Center was recently listed as a Designated Scleroderma Research and Treatment Center by the National Scleroderma Foundation.
Rheumatoid arthritis and heart disease: a common path
Patients with rheumatoid arthritis have a higher prevalence and severity of atherosclerosis than others, yet current risk scores routinely underestimate their likelihood of developing cardiovascular disease.